Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate Other stock markets 12:47:43 19/06/26 am AEST			5-day change	1st Jan Change
161.30 ^EUR	+1.45%		-1.55%	-7.51%

09:28pm	Rothschild & Co Redburn Adjusts Charles River Laboratories International PT to $241 From $230, Maintains Buy Rating	MT
18/06	Charles River Laboratories Shares Rise After Morgan Stanley Upgrade	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LONZA GROUP AG	43.44B		AAA
REVOLUTION MEDICINES, INC.	33.54B	-	B	-		-
IQVIA HOLDINGS INC.	28.48B		AAA
BEONE MEDICINES AG	29.2B		-
CELLTRION, INC.	25.34B		A
ASCENDIS PHARMA A/S	14.36B	-	-	-		-		-
MEDPACE HOLDINGS, INC.	13.05B		BBB
EUROFINS SCIENTIFIC SE	12.67B		AA
IONIS PHARMACEUTICALS, INC.	12.28B	-	A	-		-
ICON PUBLIC LIMITED COMPANY	10.97B		AAA
TEMPUS AI, INC.	8.76B		A			-
BIO-TECHNE CORPORATION	8.61B		AA
BLUEPRINT MEDICINES CORPORATION	8.38B	-	BB	-		-	-	-
REGENCELL BIOSCIENCE HOLDINGS LIMITED	7.34B	-	-	-	-	-	-	-
ABIVAX	8.16B	-	BBB	-		-
QIAGEN N.V.	7.56B		AAA
ALKERMES PLC	7.42B		A
KYMERA THERAPEUTICS, INC.	7.39B	-	BBB	-		-
PRAXIS PRECISION MEDICINES, INC.	7.53B	-	B	-		-
Average	15.5B		A
Weighted average by Cap.			A